Brookdale Senior Living Inc. (BKD)
NYSE: BKD · Real-Time Price · USD
10.21
+0.30 (3.03%)
At close: Nov 11, 2025, 4:00 PM EST
10.29
+0.08 (0.78%)
After-hours: Nov 11, 2025, 7:59 PM EST
Brookdale Senior Living Market Cap
Brookdale Senior Living has a market cap or net worth of $2.43 billion as of November 11, 2025. Its market cap has increased by 98.12% in one year.
Market Cap
2.43B
Enterprise Value
7.67B
1-Year Change
98.12%
Ranking
Category
Stock Price
$10.21
Market Cap Chart
Since November 22, 2005, Brookdale Senior Living's market cap has increased from $1.65B to $2.43B, an increase of 47.00%. That is a compound annual growth rate of 1.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2025 | 2.36B | 135.05% |
| Dec 31, 2024 | 1.00B | -8.53% |
| Dec 29, 2023 | 1.10B | 114.80% |
| Dec 30, 2022 | 510.00M | -46.68% |
| Dec 31, 2021 | 956.50M | 17.74% |
| Dec 31, 2020 | 812.40M | -39.79% |
| Dec 31, 2019 | 1.35B | 7.27% |
| Dec 31, 2018 | 1.26B | -30.43% |
| Dec 29, 2017 | 1.81B | -21.76% |
| Dec 30, 2016 | 2.31B | -32.25% |
| Dec 31, 2015 | 3.41B | -49.28% |
| Dec 31, 2014 | 6.73B | 99.09% |
| Dec 31, 2013 | 3.38B | 8.84% |
| Dec 31, 2012 | 3.10B | 47.60% |
| Dec 30, 2011 | 2.10B | -18.53% |
| Dec 31, 2010 | 2.58B | 19.61% |
| Dec 31, 2009 | 2.16B | 281.42% |
| Dec 31, 2008 | 565.70M | -80.40% |
| Dec 31, 2007 | 2.89B | -40.59% |
| Dec 29, 2006 | 4.86B | 151.15% |
| Dec 30, 2005 | 1.93B | 17.23% |
| Nov 22, 2005 | 1.65B | - |
View and export this data all the way back to 2005. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 885.19B |
| Johnson & Johnson | 466.99B |
| AbbVie | 397.96B |
| UnitedHealth Group | 296.62B |
| AstraZeneca | 275.02B |
| Novartis AG | 249.68B |
| Merck & Co. | 225.74B |
| Abbott Laboratories | 220.84B |